Partnership with Pfizer to identify novel targets for cancer therapy
The University of Melbourne has partnered with one of the world's leading biopharmaceutical companies, Pfizer, to identify and validate new targets for cancer treatment.
Professor Laura Mackay
The new partnership will provide support to immunity mechanisms research led by Professor Laura Mackay from the Peter Doherty Institute (PDI), Department of Immunology & Microbiology, in the School of Biomedical Sciences.
More information please click here.